Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- RE +8.1%, JLL +7.8%, PMD +7.2%, AVXL +6.5%, HQY +6.4%, GWPH +6%, ACM +5.7%, ALSN +5.1%, (also will buyback all of ValueAct's holdings)
- WWW +4.4%, (announces leadership appointments; indicates quarterly results were in-line with expectations), FN +4.4%, NOV +3.2%, ITUB +3.2%
- GPS +2.7%, (Gap sees Q4 EPS of $0.50-0.51 ex items, vs $0.45 consensus and reports prelim Q4 sales of $4.43 bln vs $4.39 bln CapIQ consensus; January same store sales +1% (Banana Republic -4% and Old Navy +2% vs -8.0% (BR -17%, ON -6%) year ago and +3% (BR -7%, ON +12%) last month)
- TDG +2.2%, PAHC +2%, EMR +1.8%, GM +1.5%, CHD +1.4%, CNC +1%, QSR +0.8%
Other news:
- PIP +22.8% (continued strength following yesterday's 159% move)
- ADHD +11.5% (announces FDA meeting on its ADAIR product candidate defined a 505(b)(2) development path, to be funded with existing cash balance, and targeting a 2H 2018 NDA submission)
- DRYS +6.6% (after closing near highs - up 30% on the day)
- GLBS +4.6% (after closing near highs - up 20% on the day)
Analyst comments:
- ATHX +8.6% (initiated with a Buy at Needham; tgt $7)
- NOK +2.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- CAT +1.7% (upgraded to Overweight from Equal Weight at Barclays)
- BIIB +1.7% (upgraded to Buy from Neutral at Citigroup)